Clinical trial
To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
NCT02459795 is registered in ClinicalTrials.gov with Padagis LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
- Lead sponsor
- Padagis LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- December 31, 2015
- Enrollment
- 469 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratosis